ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

332
Analysis
Health CareSouth Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
bearishCelltrion Inc
22 Oct 2018 19:04

Celltrion Inc Placement - Shorter Lockup Period Will Be an Overhang for Share Price

Ion Investment (Temasek) is looking to sell about 3.4m shares in Celltrion Inc (068270 KS) in an accelerated bookbuild worth approximately US$740m....

Share
09 Oct 2018 11:49

Smartkarma’s Week that Was in JP/​KR: King Street Vs. Toshiba, Korea's Donki, and SKT Split

Below is the list of the Japan/Korea related posts put on the Smartkarma platform last week. It was a holiday week for both Japan and Korea. So, we...

Logo
362 Views
Share
bullishSamsung C&T
04 Oct 2018 12:11

Stub Trade on Samsung C&T with BioLogics as a Sole Pair Partner

The last Samsung C&T (028260 KS) block deals ended last month on Sep 20. C&T is now free of circular shareholding links. That is, C&T...

Logo
466 Views
Share
bearishCelltrion Inc
21 Sep 2018 20:00

Celltrion: Understanding Inflectra's U.S. Challenges

Celltrion Inc (068270 KS) 's Inflectra (biosimilar of Remicade marketed in the U.S.) has struggled to gain a foothold in the market since its...

Share
bullishSamsung C&T
20 Sep 2018 22:14

Samsung C&T Placement: Finally First Step Towards a Legit Holding Company

I would take this deal. I believe the market will interpret this placement as the starting point of C&T-centered holding company conversion....

Logo
486 Views
Share
x